Company page
Innovent Biologics, Inc.
Innovent Biologics, Inc. is a public company listed on the Hong Kong Stock Exchange under the ticker 1801. The company has a market capitalization of approximately 16.88 billion HKD. Innovent focuses on the development and commercialization of innovative biologics for the treatment of various diseases.
- Ticker
- 1801:HKEX
- Asset type
- Stock
- Market cap
- $16.88B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD